Press Announcements > FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

Press Announcements > FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

02/23/2017 04:55 PM EST

The U.S. Food and Drug Administration today allowed marketing of the PhenoTest BC Kit, performed on the Pheno System. This is the first test to identify organisms that cause bloodstream infections and provide information about which antibiotics the organism is likely to respond to (antibiotic sensitivity).